Dr. Nicholas A. Butowski, MD

Dr. Butowski practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Butowski's NPI, 1184681009, was assigned on April 26, 2006. Dr. Butowski graduated from University of Illinois College of Medicine - Chicago in 1999. Dr. Butowski holds California license A74692.

Dr. Butowski's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Butowski's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Butowski practices. Vendor and product names are available with a free account.

Neurological surgery is Dr. Butowski's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Butowski is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Butowski is licensed in California.

CMS data shows 819 Medicare services from Dr. Butowski across 7 procedure codes in 2024, for 82 Medicare patients. Medicare paid $45,942 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 82 Medicare patients who saw Dr. Butowski in 2024. The largest group is 65 to 74, with 42 patients. 59% of them have high cholesterol, and 50% have high blood pressure. 26% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Butowski's median patient age at 58, with 54% women.

In 2024, Dr. Butowski wrote 89 Medicare Part D claims for 25 patients. 93% of them were for generic drugs. CMS names the drug for 29 of them, across 2 drugs with 11 or more claims each, at $1,045 in total drug cost. In 2023, CMS named 76 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Butowski for performance year 2024, reported as part of a group. Dr. Butowski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Butowski as offering telehealth.

Dmand AI links 143 papers to Dr. Butowski, published from 2006 to 2025. 2021 was the busiest year, with 8. The most frequent topics are Brain Neoplasms, Glioblastoma and Glioma. Dr. Butowski has published most often in Neuro Oncol. Dr. Butowski's most frequent co-authors are Susan M. Chang, MD, Mitchel S. Berger, MD and Jennie Webster Taylor, MD.

Dmand AI links Dr. Butowski to 15 clinical trials, 5 of them phase 2 studies. 4 are still active or recruiting. Conditions studied include Glioblastoma, Astrocytoma and Glioma. University of California, San Francisco sponsors the most, 4. Open Payments lists research payments to Dr. Butowski that name 2 trials.

CMS Open Payments shows 63 general payments to Dr. Butowski from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 76% of the total. Genentech, Inc. paid the most, $14,532. It also lists 7 research payments totaling $28,021 from 2017 to 2020, naming 2 clinical trials.

Dmand AI lists 4 awards for Dr. Butowski, most recently CMS Stage 1 EHR in 2013.

Dr. Butowski graduated from University of Illinois College of Medicine - Chicago in 1999. Dr. Butowski is a member of ASCO.

Dr. Butowski is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.